Amoxicillin clavulanic acid (co-amoxiclav) is a combination antibiotic medicine marketed under brands such as Augmentin. It combines amoxicillin with clavulanate to treat a broad range of bacterial infections, including respiratory, skin, urinary, and bite-related infections. It has been approved for medical use in the United States since 1984.
The CDC is investigating a multistate outbreak of extensively drug-resistant Salmonella Newport with an NDM-1 gene linked to Rosabella moringa powder capsules, marking the first documented outbreak of Salmonella with an NDM-1 gene in the United States.
CDC and FDA are investigating a multistate outbreak of extensively drug-resistant Salmonella Newport infections linked to Rosabella brand moringa powder capsules, with seven people sickened across seven states and three requiring hospitalization.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07202052 |
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) |
RECRUITING | PHASE2/PHASE3 |
| NCT06709196 |
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis |
RECRUITING | PHASE4 |
| NCT05079620 |
Early Antibiotics After Aspiration in ICU Patients |
TERMINATED | PHASE4 |
| NCT01015417 |
Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis |
COMPLETED | PHASE3 |
| NCT00656747 |
Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis |
COMPLETED | PHASE4 |
